Allergy Therapeutics (AGY) News Today GBX 5.20 -0.30 (-5.45%) (As of 11:52 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Allergy Therapeutics (LON:AGY) Shares Cross Below 200-Day Moving Average - Here's WhyNovember 14, 2024 | americanbankingnews.comAllergy Therapeutics (LON:AGY) Stock Price Passes Below 200 Day Moving Average - What's Next?Allergy Therapeutics (LON:AGY) Shares Cross Below 200 Day Moving Average - Here's What HappenedNovember 14, 2024 | marketbeat.comAllergy Therapeutics Shows Financial Turnaround and Clinical ProgressNovember 7, 2024 | markets.businessinsider.comAllergy Therapeutics Sees Growth and Strategic AdvancesNovember 7, 2024 | markets.businessinsider.comAllergy Therapeutics (LON:AGY) Shares Down 7.2% - Here's What HappenedAllergy Therapeutics (LON:AGY) Stock Price Down 7.2% - What's Next?October 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Up 17.6% - What's Next?Allergy Therapeutics (LON:AGY) Trading Up 17.6% - Here's What HappenedOctober 16, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Down 17.5% - Here's What HappenedAllergy Therapeutics (LON:AGY) Trading Down 17.5% - Here's What HappenedOctober 7, 2024 | marketbeat.comECU research emphasizes proper evaluation for children with potential antibiotic allergies Research From Edith ...September 18, 2024 | msn.comAllergy Therapeutics (LON:AGY) Trading Down 9.8%Allergy Therapeutics (LON:AGY) Shares Down 9.8%September 4, 2024 | marketbeat.comAllergy Therapeutics secures cash to see it through SeptemberAugust 27, 2024 | lse.co.ukAllergy Therapeutics (LON:AGY) Shares Down 8.9% Allergy Therapeutics (LON:AGY) Stock Price Down 8.9%August 27, 2024 | marketbeat.comFood Allergy Awareness Week 2024: How can new treatments target an unmet need?May 16, 2024 | msn.comBuy Rating Justified for Aquestive Therapeutics Amidst Innovative Allergy Treatment and Strong Financial ProspectsMay 10, 2024 | markets.businessinsider.comGlobal Skin Allergy Testing Market Expected to Reach $771.5 Million by 2028May 9, 2024 | tmcnet.comSkin patch improves treatment for pediatric milk allergiesMay 2, 2024 | msn.comGlobal Skin Allergy Testing Market Report 2024: Revenue Data for 2020-2022, Estimated Figures for 2023, and Forecasts for 2028 - ResearchAndMarkets.comApril 27, 2024 | businesswire.comThe most common 'inhalant' allergiesApril 18, 2024 | dailymail.co.ukAllergy Therapeutics First Half 2024 Earnings: UK£0.006 loss per share (vs UK£0.013 loss in 1H 2023)March 29, 2024 | finance.yahoo.comAIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenueMarch 28, 2024 | lse.co.ukAllergy Therapeutics plc (AGY.L)March 2, 2024 | finance.yahoo.comAllergy Therapeutics PLC AGYNovember 8, 2023 | morningstar.comAllergy Therapeutics Extends Cash Runway to End of YearNovember 6, 2023 | marketwatch.comAllergy Therapeutics (LON:AGY) dips 10.0% this week as increasing losses might not be inspiring confidence among its investorsOctober 14, 2023 | finance.yahoo.comAllergy Therapeutics to Raise GBP40.75 Mln; Mandatory Cash Offer TriggeredOctober 13, 2023 | marketwatch.comRed meat allergy caused by ticks is an 'emerging public health concern': CDCJuly 31, 2023 | abcnews.go.comWhat Is A Mold Allergy? Symptoms, Causes And TreatmentsJune 22, 2023 | forbes.comAllergy Therapeutics Shares Fall on Going Concern UncertaintyJune 19, 2023 | marketwatch.comGenerational Equity Advises Allergy, Sinus & Asthma Family Health Center in its Sale to AllerVie HealthJune 14, 2023 | technews.tmcnet.comIntellia Therapeutics stock gains on CRISPR treatment resultsJune 12, 2023 | msn.comWhy Intellia Therapeutics Stock Is Rising MondayJune 12, 2023 | msn.comAllergy Therapeutics to present key scientific findings from its research portfolioJune 9, 2023 | proactiveinvestors.comGlobal Allergy Immunotherapies Market Report 2023: Growing Consumer Awareness Towards Health Benefits of Allergy Immunotherapies Fuels the SectorMay 26, 2023 | benzinga.comGlobal Food Allergy Diagnostics And Therapeutics Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2030May 9, 2023 | marketwatch.comPeanut Allergy Therapeutics Market Projected to Reach Significant Growth Value by 2030May 5, 2023 | marketwatch.comAllergy Therapeutics peanut vaccine candidate negotiates its early clinical hurdleApril 19, 2023 | proactiveinvestors.comForm 8.3 - The Allergy Therapeutics PlcApril 11, 2023 | finance.yahoo.comNasal Spray For Allergies: What You Need To KnowApril 7, 2023 | forbes.comSpring is here—here’s what you need to survive seasonal allergiesMarch 29, 2023 | usatoday.comGlobal Mugwort Pollen and Allergies Therapeutics Drug Market : Latest Report 2029March 29, 2023 | marketwatch.com2023 Allergy Treatment Market: Best Practices of Top Players and Business Success Plans till 2030March 28, 2023 | marketwatch.comAllergy Diagnostics And Therapeutics Market by 2031March 28, 2023 | marketwatch.comWhat Kind Of Doctor Treats Allergies, And How Do I Know Which One I Should See?March 27, 2023 | abcnews.go.comAllergy Therapeutics doses first patients with peanut allergy vaccineMarch 27, 2023 | proactiveinvestors.comSpring arrives weeks early, bringing sniffling and sneezing to allergy sufferersMarch 19, 2023 | usatoday.comAllergy Diagnostics and Therapeutics Market with Top Market Players till 2029March 17, 2023 | marketwatch.comLatest "Allergy Treatment Market" to Register Strong Growth of CAGR to 2029March 16, 2023 | marketwatch.comAllergy Immunotherapies Market : Key Trends and Opportunities by State and Territory to 2029March 15, 2023 | marketwatch.comGlobal Eye Allergy Therapeutics Market Global Segments, Size, Recent Trends Till Forecast 2030 By VMReportsMarch 11, 2023 | marketwatch.comGlobal Allergy Immunotherapies Market 2023 Dynamics, Major Players, SWOT Analysis, and Business Forecast to 2030 By VMReportsMarch 10, 2023 | marketwatch.comFuture of Allergy Immunotherapies Market 2023: Comprehensive Study and Industry Trends till 2028February 22, 2023 | marketwatch.com Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! AGY Media Mentions By Week AGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGY News Sentiment▼0.670.47▲Average Medical News Sentiment AGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGY Articles This Week▼00▲AGY Articles Average Week Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APH News Today BXP News Today ANCR News Today EAH News Today STX News Today CHLL News Today CEL News Today HLN News Today HIK News Today HCM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AGY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
